Back to Search Start Over

Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease.

Authors :
Alfadda AA
Almaghamsi AM
Sherbeeni SM
Alqutub AN
Aldosary AS
Isnani AC
Al-Daghri N
Taylor-Robinson SD
Gul R
Source :
Frontiers in molecular biosciences [Front Mol Biosci] 2023 Feb 24; Vol. 10, pp. 1030661. Date of Electronic Publication: 2023 Feb 24 (Print Publication: 2023).
Publication Year :
2023

Abstract

Objective: Non-alcoholic fatty liver disease (NAFLD) and Type 2 diabetes mellitus (T2DM) often coexist and drive detrimental effects in a synergistic manner. This study was designed to understand the changes in circulating lipid and lipoprotein metabolism in patients with T2DM with or without NAFLD. Methods: Four hundred thirty-four T2DM patients aged 18-60 years were included in this study. Fatty liver was assessed by FibroScan. The comprehensive metabolic lipid profiling of serum samples was assessed by using high-throughput proton NMR metabolomics. Results: Our data revealed a significant association between steatosis and serum total lipids in VLDL and LDL lipoprotein subclasses, while total lipids in HDL subclasses were negatively associated. A significant positive association was found between steatosis and concentration of lipids, phospholipids, cholesterol, and triglycerides in VLDL and LDL subclasses, while HDL subclasses were negatively associated. Furthermore, a significant, association was observed between fibrosis and concentrations of lipids, phospholipids, cholesterol, and triglycerides in very small VLDL, large, and very large HDL subclasses. Subgroup analysis revealed a decrease in the concentrations of lipids, phospholipids, cholesterol, and other lipid biomolecules in patients using antilipemic medications. Conclusion: The metabolomics results provide evidence that patients with T2DM with higher steatosis grades have altered lipid metabolomics compared to patients without steatosis. Increased lipid, phospholipids, cholesterol, and triglycerides concentration of VLDL and LDL subclasses are associated with steatosis in patients with T2DM.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Alfadda, Almaghamsi, Sherbeeni, Alqutub, Aldosary, Isnani, Al-Daghri, Taylor-Robinson and Gul.)

Details

Language :
English
ISSN :
2296-889X
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in molecular biosciences
Publication Type :
Academic Journal
Accession number :
36911526
Full Text :
https://doi.org/10.3389/fmolb.2023.1030661